Blueprint Medicines Corp (NASDAQ:BPMC)

104.84
Delayed Data
As of 3:59pm ET
 -0.25 / -0.24%
Today’s Change
43.29
Today|||52-Week Range
106.50
+30.87%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Blueprint Medicines Corp have a median target of 104.50, with a high estimate of 122.00 and a low estimate of 77.00. The median estimate represents a -0.32% decrease from the last price of 104.84.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Blueprint Medicines Corp. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$9.26
Sales
$674.9M
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 506.06%
 
 
 
 
 
 
Growthannually 149.13%
 
 
 
 
 
 

Sales

Growthquarterly 7,989.79%
 
 
 
 
 
 
Growthannually 990.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.